Company Filing History:
Years Active: 2013
Title: Esther Monlleo Mas: Innovator in Pharmaceutical Compounds
Introduction
Esther Monlleo Mas is a prominent inventor based in Barcelona, Spain. She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific enzyme-associated disorders. Her work is vital in addressing various health issues that affect many individuals worldwide.
Latest Patents
Esther holds a patent for "Inhibitor compounds of 11-beta-hydroxysteroid dehydrogenase type 1." This patent includes compounds derived from perhydroquinoline and perhydroisoquinoline, which are useful as active pharmaceutical ingredients. These compounds are designed for the prophylaxis or treatment of diseases associated with the 11-beta-hydroxysteroid dehydrogenase type 1 (11-beta-HSD1) enzyme. The disorders targeted by her invention include glaucoma, elevated ocular pressure, metabolic disorders, obesity, metabolic syndrome, dyslipidemia, hypertension, diabetes, atherosclerosis, Cushing's syndrome, psoriasis, rheumatoid arthritis, cognitive disorders, Alzheimer's disease, and neurodegeneration. Esther has 1 patent to her name.
Career Highlights
Esther Monlleo Mas is currently associated with Laboratorios Salvat, S.A., where she continues to innovate and develop new pharmaceutical solutions. Her expertise in the field has positioned her as a key player in the research and development of effective treatments for complex health conditions.
Collaborations
Esther collaborates with notable colleagues, including Juan Lorenzo Catena Ruiz and Carme Serra Comas. These partnerships enhance her research efforts and contribute to the advancement of pharmaceutical science.
Conclusion
Esther Monlleo Mas is a remarkable inventor whose work in pharmaceutical compounds has the potential to improve the lives of many individuals suffering from various health disorders. Her dedication to innovation and collaboration in the field of medicine is commendable.